G1 Therapeutics (GTHX) PT Lowered to $42 at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Gil Blum lowered the price target on G1 Therapeutics (NASDAQ: GTHX) to $42.00 (from $44.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
